Sun Pharmaceutical Industries Ltd shares secure licensing deal for lerodalcibep
Why did Sun Pharmaceutical Industries Ltd shares fall today?
Sun Pharmaceutical Industries Ltd shares traded 0.56% lower at ₹1843.05 on Monday at 11:19 AM. The stock price movement followed an important corporate announcement made by the company.
Sun Pharma has entered into a significant global licensing, commercialization, and manufacturing agreement with LIB Therapeutics for 'Lerodalcibep', a PCSK9 inhibitor. The agreement covers the ex-US and China markets for this cardiovascular drug, which is designed to lower cholesterol. The press release also confirmed that the drug, marketed as Lyrokaul, has received approval in the European Union.
This type of large-scale licensing deal involves substantial financial commitments and future commercial prospects, which can lead to short-term share price volatility as the market assesses its potential impact on the company's finances and long-term growth.
What does Sun Pharmaceutical Industries Ltd do?
Sun Pharmaceutical Industries Limited is a company headquartered in Mumbai, Maharashtra, India, with its registered office in Vadodara, Gujarat. The company is involved in a global licensing, commercialization, and manufacturing agreement for a pharmaceutical product named lerodalcibep, a PCSK9 inhibitor.
This agreement is with LIB Therapeutics and covers markets outside of the United States and China. The product, also referred to as Lyrokaul, has received approval in the European Union. The company's operations are connected to the pharmaceutical sector, as indicated by its listing on Indian stock exchanges under the symbol SUNPHARMA.
Sun Pharmaceutical Industries Ltd Financials
In CroresSun Pharmaceutical Industries Ltd's revenue increased from ₹14,559.75 crore in March 2026 to ₹15,183.55 crore in June 2026, representing growth of approximately 4.3%. Similarly, the company's profit rose from ₹2,714.03 crore to ₹2,894.79 crore over the same period, indicating a growth of about 6.7%. Both metrics show a positive upward trend, with profit growing at a slightly faster rate than revenue.
Sun Pharmaceutical Industries Ltd Shareholding Pattern
Promoter holding stands at 54.48% of the total share capital. Foreign Institutional Investors (FIIs) hold 14.54% stake in the company, while Domestic Institutional Investors (DIIs) hold 22.06%. Public shareholders hold the remaining 8.92% stake in Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd FAQs
Q: Why did Sun shares fall 0.56% today?
Press Release for lerodalcibep licensing agreement. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Sun Pharmaceutical Industries Ltd?
As per the latest data, promoters hold 54.48% stake in Sun Pharmaceutical Industries Ltd, while FII holding stands at 14.54%. Domestic institutional investors hold 22.06%, and public shareholders account for 8.92% of the equity.
Q: What is the current stock price of Sun Pharmaceutical Industries Ltd?
Sun Pharmaceutical Industries Ltd shares are currently trading at ₹1843.05, recording a decline of 0.56% from the previous close.
Q: What is the market capitalization of Sun Pharmaceutical Industries Ltd?
The company currently has a market capitalization of ₹442209.44 crore, reflecting its valuation in the Indian equity market.